RICTOR and small cell lung carcinoma: Nevertheless, patients with RICTOR amplification in gastric and small cell lung cancer were sensible to treatment with mTOR kinase inhibitors and were subsequently identified as a subgroup that responded to the treatment (Kim et al., 2017; Sakre et al., 2017).